← Archive

Friday, April 24, 2026

EU approves 90bn euro loan for Ukraine
World

EU approves 90bn euro loan for Ukraine

The European Union has formally approved a 90 billion euro loan package for Ukraine, paired with a fresh round of sanctions on Russia. President Zelenskyy welcomed the deal and pressed Brussels to release the first tranche by May or June.

MarketRussia x Ukraine ceasefire by end of 2026?26%
12:00 AMRead →
US soldier charged for betting on Maduro raid
Politics

US soldier charged for betting on Maduro raid

A US Army master sergeant has been arrested for allegedly using classified knowledge of the January operation to capture Venezuelan president Nicolás Maduro to place winning bets on prediction market Polymarket — the first criminal case of its kind in the country. Gannon Ken Van Dyke, 38, faces up to 60 years in prison after prosecutors say he pocketed more than $400,000 on trades he placed while actively involved in planning the mission.

MarketNicolás Maduro released from custody by December 31, 2026?18%
10:37 PMRead →
Meta and Microsoft cut nearly 17,000 jobs
Economy

Meta and Microsoft cut nearly 17,000 jobs

Meta is laying off roughly 8,000 workers — about 10% of its workforce — while Microsoft is simultaneously offering voluntary buyouts to 8,750 employees, a first for the Windows maker. Both moves arrive as the companies race to redirect spending toward AI infrastructure after a bruising stretch of legal losses and market pressure for Meta.

12:00 AMRead →
Trump threatens UK with tariffs over digital tax
Politics

Trump threatens UK with tariffs over digital tax

Donald Trump has warned he will impose sweeping tariffs on the UK unless it scraps its 2% digital services tax on US tech giants, accusing Britain of trying to "make an easy buck" off American companies. The threat lands weeks after Trump signalled the existing UK-US trade framework could be renegotiated, raising fresh uncertainty over a deal both sides had been quietly pursuing.

1:35 AMRead →
FDA approves first gene therapy for deafness
Health

FDA approves first gene therapy for deafness

The FDA has cleared the first gene therapy designed to treat hereditary deafness, developed by Regeneron Pharmaceuticals. The approval targets a rare genetic form of the condition, but the milestone opens the door to gene-based treatments for a much wider range of hearing disorders.